These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 1710780
1. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Pircher H, Rohrer UH, Moskophidis D, Zinkernagel RM, Hengartner H. Nature; 1991 Jun 06; 351(6326):482-5. PubMed ID: 1710780 [Abstract] [Full Text] [Related]
2. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Pircher H, Moskophidis D, Rohrer U, Bürki K, Hengartner H, Zinkernagel RM. Nature; 1990 Aug 16; 346(6285):629-33. PubMed ID: 1696684 [Abstract] [Full Text] [Related]
6. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB. J Immunol; 1998 Nov 01; 161(9):5087-96. PubMed ID: 9794447 [Abstract] [Full Text] [Related]
7. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Kyburz D, Aichele P, Speiser DE, Hengartner H, Zinkernagel RM, Pircher H. Eur J Immunol; 1993 Aug 01; 23(8):1956-62. PubMed ID: 8344359 [Abstract] [Full Text] [Related]
8. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection. Von Herrath MG, Coon B, Oldstone MB. Virology; 1997 Mar 17; 229(2):349-59. PubMed ID: 9126248 [Abstract] [Full Text] [Related]
9. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Oehen SU, Ohashi PS, Bürki K, Hengartner H, Zinkernagel RM, Aichele P. Cell Immunol; 1994 Oct 15; 158(2):342-52. PubMed ID: 7923387 [Abstract] [Full Text] [Related]
10. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. Byrne JA, Ahmed R, Oldstone MB. J Immunol; 1984 Jul 15; 133(1):433-9. PubMed ID: 6202788 [Abstract] [Full Text] [Related]
11. CTL escape viral variants. I. Generation and molecular characterization. Lewicki H, Tishon A, Borrow P, Evans CF, Gairin JE, Hahn KM, Jewell DA, Wilson IA, Oldstone MB. Virology; 1995 Jun 20; 210(1):29-40. PubMed ID: 7793078 [Abstract] [Full Text] [Related]
12. [Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I]. Hengartner H. Verh Dtsch Ges Pathol; 1994 Jun 20; 78():177-9. PubMed ID: 7533982 [Abstract] [Full Text] [Related]
13. Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus. Hudrisier D, Riond J, Gairin JE. J Virol; 2001 Mar 20; 75(5):2468-71. PubMed ID: 11160751 [Abstract] [Full Text] [Related]
14. Limits to the differential avidity model of T cell selection in the thymus. Girao C, Hu Q, Sun J, Ashton-Rickardt PG. J Immunol; 1997 Nov 01; 159(9):4205-11. PubMed ID: 9379014 [Abstract] [Full Text] [Related]
15. Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex. Tissot AC, Ciatto C, Mittl PR, Grütter MG, Plückthun A. J Mol Biol; 2000 Sep 29; 302(4):873-85. PubMed ID: 10993729 [Abstract] [Full Text] [Related]
16. Immunological function of a defined T-cell population tolerized to low-affinity self antigens. Kawai K, Ohashi PS. Nature; 1995 Mar 02; 374(6517):68-9. PubMed ID: 7870174 [Abstract] [Full Text] [Related]
17. The level of CD4 surface protein influences T cell selection in the thymus. Frank GD, Parnes JR. J Immunol; 1998 Jan 15; 160(2):634-42. PubMed ID: 9551897 [Abstract] [Full Text] [Related]
18. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody. Seiler P, Senn BM, Bründler MA, Zinkernagel RM, Hengartner H, Kalinke U. J Immunol; 1999 Apr 15; 162(8):4536-41. PubMed ID: 10201992 [Abstract] [Full Text] [Related]
19. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion. Tomita Y, Nishimura Y, Harada N, Eto M, Ayukawa K, Yoshikai Y, Nomoto K. J Immunol; 1990 Dec 15; 145(12):4026-36. PubMed ID: 2147933 [Abstract] [Full Text] [Related]
20. Abrogation of tolerance to a chronic viral infection. Jamieson BD, Somasundaram T, Ahmed R. J Immunol; 1991 Nov 15; 147(10):3521-9. PubMed ID: 1940352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]